Boxtel, Netherlands

Johannes Jan Platteeuw

USPTO Granted Patents = 18 

 

 

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 120(Granted Patents)


Location History:

  • s'Hertogenbosch, NL (2003 - 2004)
  • Nijmegen, NL (2006)
  • Boxtel, NL (2018 - 2024)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovator Johannes Jan Platteeuw: Pioneering Pharmaceutical Solutions

Introduction

Johannes Jan Platteeuw, an accomplished inventor based in Boxtel, NL, has significantly contributed to the pharmaceutical field with his innovative inventions. With an impressive portfolio of 14 patents, his work focuses on developing advanced formulations for crucial medical treatments, particularly in oncology and therapeutic drug delivery.

Latest Patents

Among his latest patents, Platteeuw has made notable strides in the formulation of stable pharmaceutical compositions. One such patent involves stable formulations comprising thiotepa, a drug used in cancer treatment. This invention not only includes pharmaceutical compositions with thiotepa and components like PEG (such as PEG400 or PEG600), DMSO, and optional water or saline solutions, but also emphasizes the method of treating cancer or myeloablation prior to bone marrow transplantation. Importantly, the composition is designed to be free or substantially free of impurities, greatly enhancing its therapeutic potential.

Additionally, Platteeuw has developed an orodispersible dosage unit containing an estetrol component. This innovative solid pharmaceutical dosage unit weighs between 30 and 1,000 mg, comprising 0.1-25 wt. % of estetrol particles and 75-99.9 wt. % of other pharmaceutically acceptable ingredients. The design allows for easy manufacturing and is perfectly suited for sublingual, buccal, or sublabial administration, providing patients with a more accessible route for medication intake.

Career Highlights

Throughout his career, Johannes Jan Platteeuw has worked with notable companies in the pharmaceutical industry, including Estetra S.p.r.l. and Estetra Srl. His experience in these organizations has played a pivotal role in shaping his innovative approaches to drug formulation and development. Platteeuw's dedication to research and innovation has positioned him as a key figure in the pharmaceutical sector.

Collaborations

In his journey of innovation, Johannes Jan Platteeuw has collaborated with fellow experts in the field, such as Séverine Francine Isabelle Jaspart and Denny Johan Marijn Van Den Heuvel. These partnerships highlight the importance of collaboration in driving forward new ideas and achieving breakthroughs in pharmaceutical research and development.

Conclusion

Johannes Jan Platteeuw stands out as a significant contributor to the field of pharmaceuticals with his innovative formulations and patented inventions. His work not only enhances treatment options for patients facing serious health challenges but also sets a precedent for future developments in effective drug delivery systems. As the medical community continues to benefit from his research, Platteeuw's legacy as an inventor will undoubtedly inspire future generations in the pursuit of medical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…